ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
베체트병 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년까지 8.2%의 연평균 성장률(CAGR)로 17억 1,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안 예상되는 성장은 자가면역질환 및 염증성 질환에 대한 연구 증가, 임상시험 및 연구 이니셔티브 증가, 맞춤형 치료 접근법 개발, 신흥 지역의 의료 접근성 개선, 환자 중심 치료 모델에 대한 중요성 증가에 의해 주도될 것으로 보입니다. 예측 기간 동안 예상되는 주요 동향으로는 진단법 혁신, 정밀의료의 발전, 원격의료 및 디지털 헬스케어 솔루션으로의 전환, 제약기업과 연구기관의 협력 강화, 새로운 병용요법의 출현 등이 있습니다.
희귀질환에 대한 헬스케어 투자 증가는 향후 몇 년 동안 베체트병 시장의 성장을 견인할 것으로 예상됩니다. 희귀질환은 2,000명 중 1명 미만이 앓고 있는 질환으로 정의되며, 복잡한 증상과 제한된 치료 옵션이 특징인 경우가 많습니다. 이러한 투자 급증의 주요 요인은 효과적인 치료법이 없는 환자가 많고, 미충족 의료 수요에 대한 인식이 높아졌기 때문입니다. 이에 따라 정부와 제약사들은 이 분야의 연구개발과 자금 조달을 우선순위로 삼고 있습니다. 베체트병은 집중적인 연구 노력을 통해 희귀질환 전반에 대한 치료와 정책이 얼마나 큰 진전을 이룰 수 있는지를 보여주는 사례로 꼽힙니다. 예를 들어, 2024년 4월 미국 비영리단체 Global Genes는 2024년 1분기 희귀질환 치료제를 개발하는 회사들이 주식 및 채권 발행을 통해 71억 달러의 자금을 조달했다고 발표했습니다. 따라서 희귀질환에 대한 헬스케어 투자 증가가 베체트병 시장 성장에 크게 기여하고 있습니다.
베체트병 치료제 시장은 염증 및 관련 증상을 보다 효과적으로 관리하기 위해 자연방어조절제(IDRs)와 같은 면역체계 조절에 초점을 맞춘 새로운 치료법을 개발하기 위해 노력하고 있습니다. IDR은 합성 펩타이드이며, 신체의 자연 방어력을 강화하여 자연 면역 반응을 조절하도록 설계되었습니다. 베체트병의 경우, 과도한 면역 활성과 염증을 조절하여 질병의 증상을 완화하고 재발을 억제할 수 있습니다. 예를 들어, 미국 소재 바이오 제약사 Soligenix, Inc.는 2024년 11월 베체트병 환자의 면역 반응을 조절하고 염증을 완화하기 위한 IDR인 SGX945(dusketide)를 평가하기 위한 임상 2상 시험(프로토콜 번호 DUS-AUBD-01)의 환자 등록을 시작했습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계 베체트병 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 베체트병 시장 : 성장률 분석
세계의 베체트병 시장 실적 : 규모와 성장, 2019-2024년
세계의 베체트병 시장 예측 : 규모와 성장, 2024-2029년, 2034년
세계 베체트병 전체 시장(TAM)
제6장 시장 세분화
세계의 베체트병 시장 : 치료 종류별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
코르티코스테로이드
면역억제제
생물학적 제제
기타 치료법
세계의 베체트병 시장 : 투여 경로별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
경구
주사
국소
세계의 베체트병 시장 : 질병 종류별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
비안구 베체트병
안구 베체트병
세계의 베체트병 시장 : 유통 채널별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
병원 약국
소매 약국
온라인 약국
기타 유통 채널
세계의 베체트병 시장 : 최종사용자별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
병원
클리닉
외래 수술 센터
세계의 베체트병 시장 : 코르티코스테로이드 종류별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
경구 코르티코스테로이드
국소 코르티코스테로이드
정맥내 코르티코스테로이드
세계의 베체트병 시장 : 면역억제제 종류별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
메토트렉세이트
아자티오프린
사이클로포스파마이드
마이코페놀레이트 모페틸
사이클로스포린
세계의 베체트병 시장 : 생물학적 제제 종류별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
종양괴사인자(TNF) 억제제
인터류킨 억제제
세계의 베체트병 시장 : 기타 치료법 종류별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
콜히친
탈리도마이드
하이드록시클로로퀸
코르티코스테로이드-분리제제
제7장 지역별·국가별 분석
세계의 베체트병 시장 : 지역별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
세계의 베체트병 시장 : 국가별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
베체트병 시장 : 경쟁 구도
베체트병 시장 : 기업 개요
AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
GlaxoSmithKline PLC Overview, Products and Services, Strategy and Financial Analysis
Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
Sandoz International GmbH
Chugai Pharmaceutical Co. Ltd
Sun Pharmaceutical Industries Limite
Eisai Co. Ltd
Pharmascience Inc
Samsung Bioepis Co. Ltd.
Maxivision Eye Hospitals Pvt. Ltd
Ainos Inc.
Soligenix Inc
XOMA Corporation
Creabilis S.A.
Iltoo Pharma S.A.S.
Ganzhou Hemay Pharmaceutical Co. Ltd.
Sanguine Biosciences Inc.
NYU Langone Health
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
베체트병 시장 2029 : 새로운 기회를 제공하는 국가
베체트병 시장 2029 : 새로운 기회를 제공하는 부문
베체트병 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁 전략
제36장 부록
ksm
영문 목차
영문목차
Behcet's disease is a rare, chronic inflammatory condition that affects multiple systems in the body, characterized by recurring inflammation in areas such as the eyes, mouth, skin, and genitals. It is considered a type of vasculitis, involving inflammation of both large and small blood vessels.
The primary treatment options for Behcet's disease include corticosteroids, immunosuppressants, biologics, and other therapies. Corticosteroids are anti-inflammatory medications commonly used to alleviate symptoms such as eye irritation, skin lesions, and mouth ulcers by controlling inflammation. These treatments can be administered in various forms, including oral, injectable, and topical routes, and are applicable to both ocular and non-ocular forms of the disease. The medications are distributed through hospital pharmacies, retail pharmacies, online pharmacies, and other outlets. They are used by healthcare providers in hospitals, clinics, ambulatory surgical centers, and other medical facilities.
The behcets disease market research report is one of a series of new reports from The Business Research Company that provides behcets disease market statistics, including behcets disease industry global market size, regional shares, competitors with a behcets disease market share, behcets disease market segments, market trends, and opportunities, and any further data you may need to thrive in the behcets disease industry. This behcets disease market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The behcets disease market size has grown strongly in recent years. It will grow from $1.15 billion in 2024 to $1.25 billion in 2025 at a compound annual growth rate (CAGR) of 8.4%. The growth during the historic period can be attributed to increased awareness of rare diseases, the availability of biologic treatments, the expansion of healthcare infrastructure, the rising prevalence of autoimmune conditions, and greater adoption of biologic therapies.
The behcets disease market size is expected to see strong growth in the next few years. It will grow to $1.71 billion in 2029 at a compound annual growth rate (CAGR) of 8.2%. The growth anticipated in the forecast period is expected to be driven by increased research into autoimmune and inflammatory diseases, a rising number of clinical trials and research initiatives, the development of personalized treatment approaches, improved healthcare access in emerging regions, and a growing emphasis on patient-centered care models. Key trends projected for the forecast period include innovations in diagnostic methods, progress in precision medicine, a shift toward telemedicine and digital healthcare solutions, increased collaboration between pharmaceutical companies and research organizations, and the emergence of novel combination therapies.
Increasing healthcare investment in rare diseases is expected to drive the growth of the Behcet's disease market in the coming years. Rare diseases are defined as conditions affecting fewer than 1 in 2,000 people and are often marked by complex symptoms and limited treatment options. This investment surge is primarily fueled by the growing awareness of unmet medical needs, with many patients lacking effective therapies. As a result, governments and pharmaceutical companies are prioritizing research, development, and funding in this space. Behcet's disease serves as a case study demonstrating how concentrated research efforts can lead to broader advances in treatment and policy across the rare disease landscape. For example, in April 2024, Global Genes, a U.S.-based nonprofit organization, reported that in the first quarter of 2024, companies developing treatments for rare diseases raised $7.1 billion through public equity and debt financings-an increase of 307% from the $1.8 billion raised during the same period in 2023. Therefore, increased healthcare investment in rare diseases is significantly contributing to the growth of the Behcet's disease market.
Companies in the Behcet's disease market are emphasizing the development of novel treatments focused on immune system modulation, such as innate defense regulators (IDRs), to manage inflammation and associated symptoms more effectively. IDRs are synthetic peptides designed to regulate the innate immune response by enhancing the body's natural defenses. In Behcet's disease, they help control excessive immune activity and inflammation, potentially easing disease symptoms and reducing flare-ups. For instance, in November 2024, Soligenix, Inc., a U.S.-based biopharmaceutical firm, began enrolling patients for a Phase 2 clinical trial (protocol number DUS-AUBD-01) to evaluate SGX945 (dusquetide), an IDR intended to modulate the immune response and alleviate inflammation in patients with Behcet's disease.
In May 2023, Soligenix, Inc., a U.S.-based company focused on treatments for rare diseases with unmet medical needs, entered into a partnership with Silk Road Therapeutics to target Behcet's disease. Through this exclusive option agreement, Soligenix obtained rights to develop topical pentoxifylline, aiming to provide new treatment options for Behcet's disease, a chronic inflammatory condition marked by recurrent mucocutaneous ulcers. Silk Road Therapeutics is a U.S.-based biopharmaceutical company specializing in innovative therapies for rare diseases, particularly Behcet's disease.
Major players in the behcets disease market are AbbVie Inc., AstraZeneca PLC, GlaxoSmithKline PLC, Amgen Inc., Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Chugai Pharmaceutical Co. Ltd, Sun Pharmaceutical Industries Limite, Eisai Co. Ltd, Pharmascience Inc, Samsung Bioepis Co. Ltd., Maxivision Eye Hospitals Pvt. Ltd, Ainos Inc., Soligenix Inc, XOMA Corporation, Creabilis S.A., Iltoo Pharma S.A.S., Ganzhou Hemay Pharmaceutical Co. Ltd., Sanguine Biosciences Inc., NYU Langone Health
North America was the largest region in the behcets disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in behcets disease report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the behcets disease market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The behcets disease market consists of revenues earned by entities by providing services such as diagnostic testing, immunosuppressive and biologic treatment administration, patient care and support programs, surgical interventions for complications, and clinical research and development activities. The market value includes the value of related goods sold by the service provider or included within the service offering. The behcets disease market also includes sales of immunosuppressive drugs, biologic therapies, corticosteroids, colchicine, topical agents, and ophthalmic solutions. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Behcets disease Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on behcets disease market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for behcets disease ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The behcets disease market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Treatment Type: Corticosteroids; Immunosuppressants; Biologics; Other Treatments
2) By Route Of Administration: Oral; Injectable; Topical
3) By Type of Disease: Non-Ocular Behcet's Disease; Ocular Behcet's Disease
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distribution Channels
5) By End User: Hospitals; Clinics; Ambulatory Surgical Centers
Subsegments:
1) By Corticosteroids: Oral Corticosteroids; Topical Corticosteroids; Intravenous Corticosteroids
2) By Immunosuppressants: Methotrexate; Azathioprine; Cyclophosphamide; Mycophenolate Mofetil; Cyclosporine
3) By Biologics: Tumor Necrosis Factor (TNF) Inhibitors; Interleukin Inhibitors
4) By Other Treatments: Colchicine; Thalidomide; Hydroxychloroquine; Corticosteroid-Sparing Agents
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Behcets Disease Market Characteristics
3. Behcets Disease Market Trends And Strategies
4. Behcets Disease Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Behcets Disease Growth Analysis And Strategic Analysis Framework
5.1. Global Behcets Disease PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Behcets Disease Market Growth Rate Analysis
5.4. Global Behcets Disease Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Behcets Disease Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Behcets Disease Total Addressable Market (TAM)
6. Behcets Disease Market Segmentation
6.1. Global Behcets Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Corticosteroids
Immunosuppressants
Biologics
Other Treatments
6.2. Global Behcets Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Injectable
Topical
6.3. Global Behcets Disease Market, Segmentation By Type of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Non-Ocular Behcet's Disease
Ocular Behcet's Disease
6.4. Global Behcets Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Other Distribution Channels
6.5. Global Behcets Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinics
Ambulatory Surgical Centers
6.6. Global Behcets Disease Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral Corticosteroids
Topical Corticosteroids
Intravenous Corticosteroids
6.7. Global Behcets Disease Market, Sub-Segmentation Of Immunosuppressants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Methotrexate
Azathioprine
Cyclophosphamide
Mycophenolate Mofetil
Cyclosporine
6.8. Global Behcets Disease Market, Sub-Segmentation Of Biologics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Tumor Necrosis Factor (TNF) Inhibitors
Interleukin Inhibitors
6.9. Global Behcets Disease Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Colchicine
Thalidomide
Hydroxychloroquine
Corticosteroid-Sparing Agents
7. Behcets Disease Market Regional And Country Analysis
7.1. Global Behcets Disease Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Behcets Disease Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Behcets Disease Market
8.1. Asia-Pacific Behcets Disease Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Behcets Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Behcets Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Behcets Disease Market, Segmentation By Type of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Behcets Disease Market
9.1. China Behcets Disease Market Overview
9.2. China Behcets Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Behcets Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Behcets Disease Market, Segmentation By Type of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Behcets Disease Market
10.1. India Behcets Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Behcets Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Behcets Disease Market, Segmentation By Type of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Behcets Disease Market
11.1. Japan Behcets Disease Market Overview
11.2. Japan Behcets Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Behcets Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Behcets Disease Market, Segmentation By Type of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Behcets Disease Market
12.1. Australia Behcets Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Behcets Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Behcets Disease Market, Segmentation By Type of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Behcets Disease Market
13.1. Indonesia Behcets Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Behcets Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Behcets Disease Market, Segmentation By Type of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Behcets Disease Market
14.1. South Korea Behcets Disease Market Overview
14.2. South Korea Behcets Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Behcets Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Behcets Disease Market, Segmentation By Type of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Behcets Disease Market
15.1. Western Europe Behcets Disease Market Overview
15.2. Western Europe Behcets Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Behcets Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Behcets Disease Market, Segmentation By Type of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Behcets Disease Market
16.1. UK Behcets Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Behcets Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Behcets Disease Market, Segmentation By Type of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Behcets Disease Market
17.1. Germany Behcets Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Behcets Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Behcets Disease Market, Segmentation By Type of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Behcets Disease Market
18.1. France Behcets Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Behcets Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Behcets Disease Market, Segmentation By Type of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Behcets Disease Market
19.1. Italy Behcets Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Behcets Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Behcets Disease Market, Segmentation By Type of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Behcets Disease Market
20.1. Spain Behcets Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Behcets Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Behcets Disease Market, Segmentation By Type of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Behcets Disease Market
21.1. Eastern Europe Behcets Disease Market Overview
21.2. Eastern Europe Behcets Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Behcets Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Behcets Disease Market, Segmentation By Type of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Behcets Disease Market
22.1. Russia Behcets Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Behcets Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Behcets Disease Market, Segmentation By Type of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Behcets Disease Market
23.1. North America Behcets Disease Market Overview
23.2. North America Behcets Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Behcets Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Behcets Disease Market, Segmentation By Type of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Behcets Disease Market
24.1. USA Behcets Disease Market Overview
24.2. USA Behcets Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Behcets Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Behcets Disease Market, Segmentation By Type of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Behcets Disease Market
25.1. Canada Behcets Disease Market Overview
25.2. Canada Behcets Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Behcets Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Behcets Disease Market, Segmentation By Type of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Behcets Disease Market
26.1. South America Behcets Disease Market Overview
26.2. South America Behcets Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Behcets Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Behcets Disease Market, Segmentation By Type of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Behcets Disease Market
27.1. Brazil Behcets Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Behcets Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Behcets Disease Market, Segmentation By Type of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Behcets Disease Market
28.1. Middle East Behcets Disease Market Overview
28.2. Middle East Behcets Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Behcets Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Behcets Disease Market, Segmentation By Type of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Behcets Disease Market
29.1. Africa Behcets Disease Market Overview
29.2. Africa Behcets Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Behcets Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Behcets Disease Market, Segmentation By Type of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Behcets Disease Market Competitive Landscape And Company Profiles
